scholarly article | Q13442814 |
P2093 | author name string | Kristiina Vuori | |
Darren Finlay | |||
Robyn D Richardson | |||
Amy L Howes | |||
P2860 | cites work | Potential of fibroblasts to regulate the formation of three-dimensional vessel-like structures from endothelial cells in vitro. | Q51231324 |
Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. | Q54791338 | ||
Generation of multicellular tumor spheroids by the hanging-drop method | Q80212998 | ||
Novel in vitro co-culture methodology to investigate heterotypic cell-cell interactions | Q84110821 | ||
Epithelial cell coculture models for studying infectious diseases: benefits and limitations | Q21296749 | ||
Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling | Q27851446 | ||
Unraveling the microenvironmental influences on the normal mammary gland and breast cancer | Q28473677 | ||
Multicellular tumor spheroids for evaluation of cytotoxicity and tumor growth inhibitory effects of nanomedicines in vitro: a comparison of docetaxel-loaded block copolymer micelles and Taxotere® | Q28486451 | ||
The third dimension bridges the gap between cell culture and live tissue | Q29616642 | ||
Stromal fibroblasts in cancer initiation and progression | Q29618873 | ||
Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation | Q30514021 | ||
Live multicellular tumor spheroid models for high-content imaging and screening in cancer drug discovery | Q30573300 | ||
Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries | Q33251617 | ||
The microenvironment determines the breast cancer cells' phenotype: organization of MCF7 cells in 3D cultures | Q33596766 | ||
Miniaturized pre-clinical cancer models as research and diagnostic tools | Q33605145 | ||
Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines | Q33843555 | ||
HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment | Q34111958 | ||
High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array | Q34145183 | ||
The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer | Q34291977 | ||
Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines | Q34651865 | ||
Modeling tissue morphogenesis and cancer in 3D. | Q34667330 | ||
Evaluation of nanoparticle uptake in co-culture cancer models | Q34905683 | ||
Three-dimensional tissue culture models in cancer biology | Q36173561 | ||
Inhibition of mammalian target of rapamycin is required for optimal antitumor effect of HER2 inhibitors against HER2-overexpressing cancer cells | Q37456176 | ||
Small-molecule inhibitors of the human epidermal receptor family. | Q37638679 | ||
Multicellular tumor spheroids: an underestimated tool is catching up again. | Q37680413 | ||
Spheroid culture as a tool for creating 3D complex tissues | Q38075634 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cytotoxicity | Q246181 |
high-throughput screening | Q626251 | ||
P304 | page(s) | e108283 | |
P577 | publication date | 2014-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems | |
P478 | volume | 9 |
Q92008182 | 3D Cell-Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High-Content Analysis |
Q64061324 | A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology |
Q47328841 | A biomaterial screening approach reveals microenvironmental mechanisms of drug resistance |
Q51839738 | A computational method for the identification of new candidate carcinogenic and non-carcinogenic chemicals. |
Q52611695 | A modified 384-well-device for versatile use in 3D cancer cell (co-)cultivation and screening for investigations of tumor biology in vitro. |
Q38740982 | A simple, reliable method for high-throughput screening for diabetes drugs using 3D β-cell spheroids |
Q38329647 | Addressing the right targets in oncology: challenges and alternative approaches |
Q35590169 | Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation |
Q38838243 | Cancer drug discovery: recent innovative approaches to tumor modeling |
Q37478076 | Collagen Extracted from Persian Gulf Squid Exhibits Anti-Cytotoxic Properties on Apple Pectic Treated Cells: Assessment in an In Vitro Bioassay Model |
Q41525387 | Comparative Analysis of 3D Bladder Tumor Spheroids Obtained by Forced Floating and Hanging Drop Methods for Drug Screening. |
Q47797772 | Dispersible oxygen microsensors map oxygen gradients in three-dimensional cell cultures |
Q38703364 | Effect of silibinin-loaded nano-niosomal coated with trimethyl chitosan on miRNAs expression in 2D and 3D models of T47D breast cancer cell line. |
Q38729111 | ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology |
Q48102897 | Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid |
Q51775979 | GILA, a Replacement for the Soft-Agar Assay that Permits High-Throughput Drug and Genetic Screens for Cellular Transformation. |
Q39310030 | Generation and manipulation of hydrogel microcapsules by droplet-based microfluidics for mammalian cell culture |
Q50032174 | High-Content Screening Comparison of Cancer Drug Accumulation and Distribution in Two-Dimensional and Three-Dimensional Culture Models of Head and Neck Cancer |
Q28834438 | High-throughput fluorescence imaging approaches for drug discovery using in vitro and in vivo three-dimensional models |
Q35494483 | Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors |
Q37107139 | Liquid-based three-dimensional tumor models for cancer research and drug discovery |
Q33599243 | Modeling nasopharyngeal carcinoma in three dimensions |
Q35985227 | Multilayered, Hyaluronic Acid-Based Hydrogel Formulations Suitable for Automated 3D High Throughput Drug Screening of Cancer-Stromal Cell Cocultures. |
Q38742565 | Novel 3-D cell culture system for in vitro evaluation of anticancer drugs under anchorage-independent conditions |
Q47131461 | Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: lessons learned from the inhibition of EGFR signaling. |
Q64894898 | PLA Electrospun Scaffolds for Three-Dimensional Triple-Negative Breast Cancer Cell Culture. |
Q38813025 | Progress towards understanding heterotypic interactions in multi-culture models of breast cancer |
Q36093099 | Recapitulating epithelial tumor microenvironment in vitro using three dimensional tri-culture of human epithelial, endothelial, and mesenchymal cells |
Q50868047 | Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine. |
Q64063031 | Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma |
Q36294010 | Spatial mapping of the biologic effectiveness of scanned particle beams: towards biologically optimized particle therapy. |
Q36356303 | Spontaneously-forming spheroids as an in vitro cancer cell model for anticancer drug screening |
Q41272286 | The Volume of Three-Dimensional Cultures of Cancer Cells InVitro Influences Transcriptional Profile Differences and Similarities with Monolayer Cultures and Xenografted Tumors |
Q39396046 | The production of 3D tumor spheroids for cancer drug discovery |
Q38400577 | Transcriptome modeling and phenotypic assays for cancer precision medicine |
Q39388967 | Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment. |
Search more.